首页|灵芝调脂茶对高血压合并高脂血症患者代谢指标及肾素-血管紧张素-醛固酮系统的影响探讨

灵芝调脂茶对高血压合并高脂血症患者代谢指标及肾素-血管紧张素-醛固酮系统的影响探讨

扫码查看
目的 观察灵芝调脂茶对高血压合并高脂血症患者代谢指标及肾素-血管紧张素-醛固酮系统(RAAS)的影响。方法 101例高血压合并高脂血症患者为研究对象,按照随机数字表法分为治疗组(57 例)和对照组(54 例)。两组均指导健康生活方式,对照组口服苯磺酸氨氯地平、瑞舒伐他汀治疗,治疗组在对照组基础上饮用灵芝调脂茶。比较两组治疗前后空腹血糖(FPG)、血脂指标[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]、尿酸(UA)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、RAAS[肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)]。结果 两组治疗后TC、TG、LDL-C水平均较治疗前明显下降,HDL-C水平上升,且治疗组FPG、UA水平较治疗前明显下降,差异有统计学意义(P<0。05);对照组治疗后FPG、UA水平与治疗前比较无明显统计学意义(P>0。05);相比对照组,治疗组治疗后TC、TG、LDL-C水平下降更为显著,HDL-C水平上升更为明显,差异有统计学意义(P<0。05);两组治疗后FPG、UA组间比较无明显统计学意义(P>0。05)。两组治疗后FINS及HOMA-IR较治疗前均有下降,差异有统计学意义(P<0。05);治疗组治疗后FINS(89。51±33。00)pmol/L、HOMA-IR(3。16±1。44)均低于对照组的(104。09±38。76)pmol/L、(3。81±1。67),差异有统计学意义(P<0。05)。治疗组治疗后PRA、AngⅡ、ALD均较治疗前明显下降,差异有统计学意义(P<0。05);对照组治疗前后PRA无显著性差异(P>0。05);对照组治疗后AngⅡ、ALD均较治疗前明显下降,差异有统计学意义(P<0。05)。治疗组治疗后PRA(1。61±0。74)ng/(ml·h)、AngⅡ(87。19±10。05)pg/ml、ALD(112。08±30。85)pg/ml均低于对照组的(2。02±0。32)ng/(ml·h)、(93。08±14。80)pg/ml、(128。25±25。25)pg/ml,差异有统计学意义(P<0。05)。两组患者治疗期间均未发生严重不良反应。结论 灵芝调脂茶治疗高血压合并高脂血症疗效确切,能有效控制血脂,改善HOMA-IR,调节RAAS系统,安全性好,是值得临床广泛使用的中药制剂。
Effects of Ganoderma Tiaozhi Tea on metabolic indicators and renin angiotensin aldosterone system in hypertension and hyperlipidemia
Objective To observe the effect of Ganoderma Tiaozhi Tea on metabolic indicators and renin-angiotensin-aldosterone system(RAAS)in hypertension and hyperlipidemia.Methods 101 patients with hypertension and hyperlipidemia were selected as the research subjects.They were divided into a treatment group(57 cases)and a control group(54 cases)according to the random numerical table.Both groups were instructed to live a healthy lifestyle.The control group was treated with oral amlodipine besylate and rosuvastatin,and the treatment group was treated with Ganoderma Tiaozhi Tea on the basis of the control group.Both groups were compared in terms of fasting plasma glucose(FPG),lipid lipids[total cholesterol(TC),triglyceride(TG),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C)],uric acid(UA),fasting insulin(FINS),insulin resistance index(HOMA-IR),RAAS[plasma rennin activity(PRA)],Angiotensin Ⅱ(Ang Ⅱ),aldosterone(ALD)]before and after treatment.Results After treatment,the levels of TC,TG and LDL-C in both groups decreased more significantly compared with those before treatment,and the level of HDL-C increased;the levels of FPG and UA in the treatment group decreased more significantly compared with those before treatment.The difference was statistically significant(P<0.05).The levels of FPG and UA in the control group after treatment were not statistically significant compared with those before treatment(P>0.05).Compared with the control group,the levels of TC,TG and LDL-C in the treatment group decreased more significantly after treatment,and the level of HDL-C increased more significantly.The difference was statistically significant(P<0.05).After treatment,there was no significant difference in FPG and UA between the two groups(P>0.05).After treatment,FINS and HOMA-IR in both groups decreased compared with those before treatment,and the difference was statistically significant(P<0.05).After treatment,the treatment group had FINS of(89.51±33.00)pmol/L and HOMA-IR of(3.16±1.44),which were lower than(104.09±38.76)pmol/L and(3.81±1.67)in the control group,and the difference was statistically significant(P<0.05).After treatment,PRA,Ang Ⅱ and ALD in the treatment group decreased more significantly compared with those before treatment,and the difference was statistically significant(P<0.05).There was no significant difference in PRA in the control group before and after treatment(P>0.05).After treatment,Ang Ⅱ and ALD in the control group decreased more significantly compared with those before treatment,and the difference was statistically significant(P<0.05).After treatment,the treatment group had PRA of(1.61±0.74)ng/(ml·h),Ang Ⅱ of(87.19±10.05)pg/ml and ALD of(112.08±30.85)pg/ml,which were lower than(2.02±0.32)ng/(ml·h),(93.08±14.80)pg/ml and(128.25±25.25)pg/ml in the control group.The difference was statistically significant(P<0.05).No serious adverse reactions occurred in both groups during treatment.Conclusion Ganoderma Tiaozhi Tea has a definite therapeutic effect on hypertension combined with hyperlipidemia.It can effectively control blood lipids,improve HOMA-IR,regulate the RAAS system,and has good safety.It is a worthwhile traditional Chinese medicine preparation.

HypertensionHyperlipidemiaGanoderma Tiaozhi TeaMetabolic disordersRenin-angiotensin-aldosterone system

朱琳、郑梅生、邹静

展开 >

241000 安徽省芜湖市中医医院

高血压 高脂血症 灵芝调脂茶 代谢紊乱 肾素-血管紧张素-醛固酮系统

安徽省教育厅高等学校自然科学研究重点项目(2020)

KJ2020A0876

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(5)
  • 23